Seagen Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo
- Jury Upholds Validity of Asserted Claims of the Patent, Finds Willful Infringement and Issues Past Damages Award of $41.82 Million -- Seagen to Request Royalty on Future U.S. Sales of Enhertu® Through the Life of the Patent -- Separate Arbitration Proceedings with Daiichi Sankyo Remain Ongoing with a Decision Expe...
Source: pharmiweb.com
